172 filings
Page 6 of 9
8-K
4gm87e2 qc
12 Oct 18
Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
7:00am
8-K
osgmmrrvhg5y
11 Oct 18
Regulation FD Disclosure
7:00am
8-K
mphbik7bmkc4
1 Oct 18
Trevena announces completion of leadership transition and appointment of new director
4:29pm
8-K
9of3von1
2 Aug 18
Trevena Reports Second Quarter 2018 Financial Results
7:03am
8-K
ynxtt d2qbc8g
15 Jun 18
Entry into a Material Definitive Agreement
4:59pm
8-K
1wdr2 76ejstt1n
13 Jun 18
Departure of Directors or Certain Officers
12:00am
8-K
j76bg xkyk
21 May 18
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
vvywtq3 c77
3 May 18
Trevena Reports First Quarter 2018 Financial Results
12:00am
8-K
vo2ik1145nzlm9spo
12 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
pwlumjbkzeokphgoh0
6 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
3ss2r1t4io9 of2ta
7 Mar 18
Trevena Reports Full Year 2017 Earnings
12:00am
8-K
0qi1z
2 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
93jilxs7pyfg
2 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
o319us80y n7
5 Jan 18
Trevena Announces FDA Acceptance for Review of New
12:00am
8-K
zba58bmip 3edu2
7 Nov 17
Trevena Reports Third Quarter 2017 Financial Results and Announces New Positive Clinical Trial Data
12:00am
8-K
bkg0a
13 Oct 17
Trevena Announces Restructuring to Focus Resources on Commercial Strategy
12:00am
8-K
8jfn 6qjf11nl03pjj
3 Aug 17
Trevena Reports Second Quarter 2017 Financial Results and Provides Corporate Update
12:00am
8-K
k1o5u 3rd8hqk3
16 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
w0p 6ps0v7crabqhhwru
19 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
zxr632p5
4 May 17
Trevena Reports First Quarter 2017 Financial Results and Provides Corporate Update
12:00am